Mei Ying Zhu
Chief Tech/Sci/R&D Officer at WUXI XDC CAYMAN INC.
Profile
Mei Ying Zhu is currently the Chief Technology Officer at WuXi XDC Cayman, Inc. She previously worked as the Chief Executive Officer at MabPlex USA, Inc., Associate Director at Xencor, Inc., Senior Director-Process Sciences & Manufacturing at Astellas Pharma, Inc., and Manager-Bioprocess Development at Bristol-Myers Squibb International Corp.
She also served as the Chief Technology Officer at RemeGen Co., Ltd.
from 2019 to 2023.
Zhu holds a graduate degree from the Illinois Institute of Technology, an undergraduate degree from Tsinghua University, and a doctorate from the University of Wisconsin Business School.
Mei Ying Zhu active positions
| Companies | Position | Start |
|---|---|---|
| WUXI XDC CAYMAN INC. | Chief Tech/Sci/R&D Officer | 2023-05-31 |
Former positions of Mei Ying Zhu
| Companies | Position | End |
|---|---|---|
| REMEGEN CO., LTD. | Chief Tech/Sci/R&D Officer | 2023-06-30 |
| Bristol-Myers Squibb International Corp. | Corporate Officer/Principal | - |
| XENCOR, INC. | Private Equity Analyst | - |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
MabPlex USA, Inc.
 MabPlex USA, Inc. BiotechnologyHealth Technology MabPlex USA, Inc. is a biopharmaceutical contract manufacturer that specializes in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. The American company offers a range of services including regulatory services, medium manufacturing, CMC strategy, management, and communication. MabPlex provides end-to-end CMO services such as cell banking, protein-related drug DS/DP manufacturing, ADC DS/DP manufacturing, and product testing. The private company is an industry-leading company that provides CDMO services for biologics, with a focus on antibody drug conjugates, research, development, manufacturing, and regulatory services. | Chief Executive Officer | - |
Training of Mei Ying Zhu
| Illinois Institute of Technology | Graduate Degree |
| Tsinghua University | Undergraduate Degree |
| University of Wisconsin Business School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| XENCOR, INC. | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| REMEGEN CO., LTD. | Health Technology |
| WUXI XDC CAYMAN INC. | Commercial Services |
| Private companies | 2 |
|---|---|
| Bristol-Myers Squibb International Corp. | |
MabPlex USA, Inc.
MabPlex USA, Inc. BiotechnologyHealth Technology MabPlex USA, Inc. is a biopharmaceutical contract manufacturer that specializes in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. The American company offers a range of services including regulatory services, medium manufacturing, CMC strategy, management, and communication. MabPlex provides end-to-end CMO services such as cell banking, protein-related drug DS/DP manufacturing, ADC DS/DP manufacturing, and product testing. The private company is an industry-leading company that provides CDMO services for biologics, with a focus on antibody drug conjugates, research, development, manufacturing, and regulatory services. | Health Technology |
- Stock Market
- Insiders
- Mei Ying Zhu